2016/04/22 03:05 
主訴(Chief Complaint) 
Informant:patient
Progressive dyspnea with fever for 2 days 
病史(Brief History) 
This 30-year-old lady has a high grade right breast intraductal carcinoma, pT2N3aM1, stage IV, ER(-), PR(-), Her-2(3+/3+), status right breast conserving therapy and axillary lymph node dissection on 2012/06/08, status post CE90*4 -> TH *4, leuplin (2012/07/16~2012/11/19), status post Herceptin (2012/12/31~2013/9/30), status post adjuvant RT, with brain, lung, liver mets, status post whole brain RT, status post Xeloda + lapatinib(2015/9/8-2016/02/04).

She received a regular follow-up at the out-patienit clinic of Oncology,  radio-oncology, and GYN departments.  In Feburary 2016, she was hospitalized due to bone mets and spinal cord compression, which presented with bilateral leg weakness, She then recevied T 5-6 and T12 laminectomy for epidural tumor excision and posterior fixation on 2016/02/04.  During hospitalization, wild type Acinetobactor baumanni bacteremia occurred and was treatment with ceftazidime(2016/02/12-2016/02/19) and brosym(2016/02/19-2016/02/25).  The subsequent culture resuls were negative so she was discharged on 2016/02/25.  

Due to disease progression, she had received oral chemotherapy with UFUR(2cap, BID)  and cyclophosphamide(50mg, QD)  since 2016/02/28.  She tolerated oral Vinorelbine(30mg, TIW) in 2016/03. She received radiotherapy for T4-T7 and T11-L1 metastases from 2016/03/11 to 2016/03/28.  Porta-A implantation was don on 2016/03/29.  During treatment above, she had intermittent cough and exertional dyspnea in late March. The CXR noticed  multiple lung tumors and right side plerual effusion. Thoractocentasis was done on 2016/03/30.  Exertional dyspnea improved then.  She received two cycle of  Vinorelbine(IF 50mg) on 2016/04/08(I) and 2016/04/15(II).  

However, dyspnea developed again 5 days before admission. She also experienced fever, dysuria, general malaise, and nausea two days later.  The appetite decreased and the oral intake decreased; there was no stool passage for 1 week. Her urine output decreased significnatly then. Due to high fever, she came to ED on 2016/04/21.  Upon ED arrival, her blood pressure was 122/63mmHg, the pulse rate 178bpm, the temperature 39.7 degree celcius. The CXR showed cardiomegaly and right side pleural effusion. The lab exam showed severe neutropenia(WBC 100/ul) and lactic acidosis. Empirical Maxipime was administered but shock developed later. The Maxipime was changed to Tienam for ESBL coverage. Due to profound shock, she was admitted to ICU for further treatment.

Family History:  no malignancy history in her family
Medication Allergy: 
Iopromide (Ultravist 370 76.9% 200 mL/btl 常備藥) 【Angioedema(血管水腫)】 本院醫事人員確認2012/06/13
Current Medication:
-NTUH:
1.Naposin 250 mg/tab : PO 1 tab BIDPC 21 days 42 tab
2.Prometin 5 mg/tab : PO 1 tab TIDAC30 21 days 63 tab
3.(管4) Rivotril 0.5 mg/tab : PO 1 tab HS 21 days 21 tab
4.SOLAXIN 200 mg/tab : PO 1 tab TIDPC 21 days 63 tab
-Other: nil
-中草藥:nil
-保健食品: nil
Past Medical History:
1. High grade right breast intraductal carcinoma, pT2N3aM1, stage IV, ER(-), PR(-), Her-2(3+/3+), status right breast conserving therapy and axillary lymph node dissection on 2012/06/08, status post CE90*4 -> TH *4, leuplin (2012/07/16~2012/11/19), status post Herceptin (2012/12/31~2013/9/30), status post adjuvant RT, with brain, lung, liver mets, status post whole brain RT, status post Xeloda + lapatinib(2015/9/8-2016/02/04), disease progression with bone mets and spinal cord compression, status post T5-6, T12 laminectomy for epidural tumor excision and posterior fixation with transpedicular screws on 2016/02/04, s/p oral chemotherapy with UFUR(2cap, BID)  and cyclophosphamide(50mg, QD)(2016/02/28-2016/03/07), s/p oral Vinorelbine(30mg, TIW) in 2016/03/09-3/20, s/p Porta-A implantation on 2016/03/29, s/p Vinorelbine(I) on 2016/04/08(I) and Vinorelbine(II) on 2016/04/15.
Hospitalization:
-NTUH:
入院日期:2015_03_27 出院日期:2015_03_31 診斷:Normal spontaneous delivery with 2° perineal laceration
Past Surgical History:
-NTUH:
2014_10_17 Port-A catheter Removal
2016_02_04 T5-6, T12 lamienectomy for epidural tumor excision and posterior fixation with transpedicular screws
Travel History: nil
Occupation: nil
Contact: nil
Cluster: nil 
社會心理相關評估(Psychosocial Assessment) 
Social Economic and Personal History
教育程度:高中
職業:家管
宗教信仰:無
婚姻狀態:已婚
使用語言:國語 
口述血型:A，RH:不清楚，輸血反應:不清楚
抽煙:沒有
喝酒:沒有
檳榔:沒有
物質濫用:沒有

Fall Risk Assessment
總分:9
(>=3分進行不倒翁計畫，請開預防跌倒醫囑) 
系統性回顧(Review of System) 
General: fatigue(+) anorexia(+) fever(+ 2 days) chillness(-) body weight loss(-)
Head: headache(-) dizziness(-) trauma(-)
Eyes: visual acuity(normal) dry & soreness(-)
Ears: hearing impairment(-) earache(-) tinnitus(-) discharge(-)
Nose: nose discharge(-) obstruction(-) epistaxis(-) rhinitis(-) sinusitis(-)
Mouth: sore mouth(-) sore tongue(-) bleeding gum(-) toothache(-)
Throat: sore throat(-) tonsillitis(-) dysphagia(-) dry throat(-)
Neck: mass(-) neck stiffness(-) pain(-)
Respiratory System: cough(+ dry cough, 5 days) sputum(-) hemoptysis(-) wheezing(-) dyspnea(+ 5 days)
CV System: chest tightness or pain(-) palpitation(-) varicose vein(-) orthopnea(-)  pedal edema(-)
GI System: nausea(+ 2days) vomiting(-) belching(-) heart burn(-) diarrhea(-) constipation(+ one week) hemorrhoid(-)
GU System: dysuria(+ 2days) polyuria(-) nocturia(-) hematuria(-) incontinence(-) abnormal urine color(-)
Neuromuscular System:
     Motor: muscle atrophy(-) involuntary movement(-) weakness and soreness(-) bilateral shoulders and hips atrophy(-)
     Sensory: numbness(-) hyperesthesia(-)
Extremities: swelling(-) edema(-) deformity(-) stiffness(-)
Skin: pigmentation(-) itching(-) petechiae(-) 
身體檢查(Physical Examination) 
BH: 161 cm,  BW: 68.7 kg,
T: 38.1 °C,  P: 134 bpm,  R: 37 /min,
BP: 104 / 64 mmHg,
Pain score:  0,

Neurological Examination: 
. Consciousness: clear but agitated
. Muscle power: symmetric
. Gait: bed-rest

‧Head-Eye-ENT
Conjunctiva: pink; Sclera: anicteric; 
Pupil: isocoric(3mm/3mm); reflex (+/+)
‧Neck supple
‧Chest: decreased breath sounds, bilateral, 
‧Heart: Increased cardiac size by percussion(-)
Heart beat: regular; Murmurs(-)
‧Abdomen: Flat & soft
Bowel sound: normo-active
Tenderness(-) Hepato-jugular reflux(-)
Liver and spleen: impalpable
‧Extremities: 
Freely movable, pitting edema (-), pulsations: symmetric
‧Skin
Abnormal pigmentation(-) Petechiae(-) Purpura(-) Ecchymoses(-) Rash(-) 
‧Inguinal lymphadenopathy(-); Axillary lymphadenopathy (-) 
檢驗紀錄(Laboratory Report) 
*********檢驗室:RL***********

群組:

               BUN(U)        CRE(U)        CK-MB        
time/item      (mg/dL)       (mg/dL)       (ng/mL)      
1050421 [2159] 139.0         20                         
1050421 [2251]                             6.80         
群組:Biochemistry

               BUN           CRE           Na            K             Cl           
time/item      (mg/dL)       (mg/dL)       (mmol/L)      (mmol/L)      (mmol/L)     
1050421 [2124] 18.3          1.1           133           3.1           102          
1050421 [2159]                                                                      
               T-BIL         Lipase        Ca            Mg            P            
time/item      (mg/dL)       (U/L)         (mmol/L)      (mmol/L)      (mg/dL)      
1050421 [2124] 2.27          3             1.66          0.58          1.9          
1050421 [2159]                                                                      
               LacticAcid    CK            Na(U)        
time/item      (mmol/L)      (U/L)         (mmol/L)     
1050421 [2124] 9.09          269                        
1050421 [2159]                             11           
群組:General BioChemistry

               GGT           ALB           D-BIL         ALT           ALP          
time/item      (U/L)         (g/dL)        (mg/dL)       (U/L)         (U/L)        
1050421 [2124]               2.6           1.67          19                         
1050421 [2159] 218                                                     219          
群組:Yes

               hsCRP         NT-pro BNP   
time/item      (mg/dL)       (pg/mL)      
1050421 [2124] 22.70         >35000       
*********檢驗室:YM***********

群組:

               Free Ca(急重症自  K+(急重症自行檢驗)   Na(急重症自行檢驗)  
               行檢驗)                                     
time/item      (mmol/L)      (mmol/L)      (mmol/L)     
1050421 [2157] 1.04          3.21          134.4        
群組:Yes

               pH            pCO2          pO2           HCO3          BaseExcess   
time/item      ()            (mmHg)        (mmHg)        (mmol/L)      (mmol/L)     
1050421 [2157] 7.380         19.9          122.6         11.9          -13.5        
               SO2          
time/item      (%)          
1050421 [2157] 98.8         

*********檢驗室:BC***********

群組:General BioChemistry

               T-BIL         UN           
time/item      (mg/dL)       (mg/dL)      
1050407 [1443] 1.28          14.1         
*********檢驗室:RL***********

群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (K/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1050407 [1443] 4.24          3.61          10.4          31.0          85.9         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (K/μL)        (%)           ()           
1050407 [1443] 28.8          33.5          395           19.5          -            
群組:WBC Classification

               Blast         Promyl.       Myelo.        Meta          Band         
time/item      (%)           (%)           (%)           (%)           (%)          
1050407 [1443] 0.0           0.0           1.0           4.0           2.0          
               Seg           Eos.          Baso.         Mono.         Lym.         
time/item      (%)           (%)           (%)           (%)           (%)          
1050407 [1443] 42.0          2.0           1.0           15.0          31.0         
               Aty.Lym.      PlasmaCell    Normobl.      PS           
time/item      (%)           (%)           ()            ()           
1050407 [1443] 2.0           0.0           0.0 /100 WBC  WBC 100                    
群組:Biochemistry

               CRE           AST          
time/item      (mg/dL)       (U/L)        
1050407 [1443] 0.4           119          
群組:General BioChemistry

               ALT          
time/item      (U/L)        
1050407 [1443] 25           
*********檢驗室:CY***********

群組:Yes

               Pleural Effu  Specimen Ade 
               sion Cytolog  quacy        
               y                          
time/item      (*)           (*)          
1050330 [1601] Positive for  Satisfactory 
                malignant c   for evaluat 
               ells          ion          

*********檢驗室:RL***********

群組:Biochemistry

               BUN           CRE           Na            K             LacticAcid   
time/item      (mg/dL)       (mg/dL)       (mmol/L)      (mmol/L)      (mmol/L)     
1050421 [0611] 14.8          1.2           134           3.2                        
1050421 [0907]                                                         12.71        
1050421 [1641]                                           3.6           9.12         
               CK            Troponin I   
time/item      (U/L)         (ng/mL)      
1050421 [0611] 115           0.015        
1050421 [0907]                            
1050421 [1641]                            
群組:Coagulation

               PT            PTT           PT INR       
time/item      (sec)         (sec)         ()           
1050421 [0907] 17.1          47.4          1.60         
1050421 [1641] 18.5                        1.76         
群組:

               CK-MB         Mucus(S)     
time/item      (ng/mL)       (*)          
1050421 [0611] <0.300                     
1050421 [1433]               +            
群組:SEDIMENT

               RBC(S)        WBC(S)        EpithCell(S)  Cast(S)       Crystal(S)                 
time/item      (/HPF)        (/HPF)        (/HPF)        (/LPF)        (*)          
1050421 [1433] 2-5           10-20         10-20         Gr(5-10)      -            
               Bacteria      Others(S)    
time/item      (*)           (*)          
1050421 [1433] 3+            -            
群組:MULTISTIX

               Sp. Gr.(C)    pH(C)         Protein(C)    Glu.(C)       Ketones(C)   
time/item      (*)           (*)           (mg/dL)       (mg/dL)       (*)          
1050421 [1433] 1.025         5.5           300 ( 3+ )    30 ( +/- )    +/-          
               O.B.(C)       Urobil.(C)    Bil.(C)       Nitrite(C)    WBC(C)       
time/item      (*)           (mg/dL)       (*)           (*)           (*)          
1050421 [1433] +/-           4.0           1+            -             -            
               Color         Turbidity    
time/item      (*)           (*)          
1050421 [1433] Dark Yellow   2+           
群組:Blood pH/Gas

               PH            PCO2          PO2           HCO3          BaseExcess   
time/item      (*)           (mmHg)        (mmHg)        (mmol/L)      (mmol/L)     
1050421 [0611] 7.438         20.0          39.9          13.6          -10.8        
群組:General BioChemistry

               ALT          
time/item      (U/L)        
1050421 [0611] 16           
群組:WBC Classification

               Blast         Promyl.       Myelo.        Meta          Band         
time/item      (%)           (%)           (%)           (%)           (%)          
1050421 [0611] 0.0           0.0           0.0           0.0           0.0          
               Seg           Eos.          Baso.         Mono.         Lym.         
time/item      (%)           (%)           (%)           (%)           (%)          
1050421 [0611] 3.0           0.0           2.0           0.0           5.0          
               Aty.Lym.      PlasmaCell    Normobl.      PS           
time/item      (%)           (%)           ()            ()           
1050421 [0611] 0.0           0.0           0.0 /10 WBC   WBC 10X10    
群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (K/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1050421 [0611] 0.10          2.76          7.7           23.2          84.1         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (K/μL)        (%)           ()           
1050421 [0611] 27.9          33.2          326           19.0          -            
*********檢驗室:YM***********

群組:

               Free Ca(急重症自  K+(急重症自行檢驗)   Na(急重症自行檢驗)   Suger(急重症自行檢  LacticAcid(急 
               行檢驗)                                      驗)            重症自行檢驗)      
time/item      (mmol/L)      (mmol/L)      (mmol/L)      (mg/dL)       (mmol/L)     
1050421 [0859] 1.08          2.81          133.7         101           11.3         
1050421 [1635] 1.07          3.61          134.6                       7.6          
群組:Yes

               pH            pCO2          pO2           HCO3          BaseExcess   
time/item      ()            (mmHg)        (mmHg)        (mmol/L)      (mmol/L)     
1050421 [0859] 7.316         25.3          47.9          13.0          -13.4        
1050421 [1635] 7.326         25.0          33.4          13.2          -13.1        
               SO2          
time/item      (%)          
1050421 [0859] 81.0         
1050421 [1635] 61.5         
*********檢驗室:BK***********

群組:Yes

               antibody scr 
               een(New Lis)               
time/item      (*)          
1050421 [0907] Negative     
群組:Blood Type

               ABO Typing    RH Typing    
time/item      (*)           (*)          
1050421 [0907] A             Positive     
*********檢驗室:PO***********

群組:

               Sugar(One to 
               uch)         
time/item      (*)          
1050421 [2156] 192 
檢查紀錄(Examination Report) 
nil. 
影像報告(Imaging Report) 
Chest : PA View (Standing) 醫令: Chest : PA View (Standing) 報告醫師: 葉建德 影像時間: 2016/04/21 05:42 (32001CXM) 發報告時間: 2016/04/21 16:44 cardiomegaly. ill-defined opacities in bilateral lungs. placement of a left Port-A catheter. postoperative changes of the spine.
Chest : AP View (Supine) 醫令: Chest : AP View (Supine) 報告醫師: 葉建德 影像時間: 2016/04/21 18:03 (32001CYM) 發報告時間: 2016/04/21 19:43 Cardiomegaly. Bilateral lung consolidation. Postoperative changes of spine. Placement of central venous catheter(s), portacath. Suggest clinical correlation. Compression fracture of spine.
Chest : AP View (Supine) 醫令: Chest : AP View (Supine) 報告醫師: 陳佾昌 影像時間: 2016/04/21 13:33 (32001CYM) 發報告時間: 2016/04/21 15:12 Chart No: 5840410
Accession No: T0160063362
EXAMINATION: Chest - AP View (Supine).
FINDINGS:
Cardiomegaly. Bilateral lung consolidation. Postoperative changes of spine. Placement of central venous catheter(s), portacath. Suggest clinical correlation. Compression fracture of spine.
Abdomen:KUB 醫令: Abdomen:KUB 報告醫師: 葉建德 影像時間: 2016/04/21 05:42 (32006C0M) 發報告時間: 2016/04/21 16:54 non-specific bowel gas pattern. no abnormal calcifications. postoperative changes of the spine.
Chest : AP View (Supine) 醫令: Chest : AP View (Supine) 報告醫師: 黃旭辰 影像時間: 2016/03/29 13:30 (32001CYM) 發報告時間: 2016/03/30 21:20 right lung consolidation. right pleural effusion. nodules and ill-defined opacities at left lung. placement of a port A catheter. postoperative change at spine.
Chest : PA View (Standing) 醫令: Chest : PA View (Standing) 報告醫師: 王郁棻 影像時間: 2016/03/29 15:13 (32001CXM) 發報告時間: 2016/03/29 17:53 chest X ray shows: s/p Port-A catheter placement. s/p operative change at thoracolumbar spine.  multiple nodular lesions and patchy consolidation of both lungs. elevation of right diaphragm, right pleural effusion. 
病理報告(Pathology Report) 
S1221189
Breast,right,partial mastectomy,invasive ductal carcinoma grade II,   
Lymph node,axillary, sentinel 1, right,lymphadenectomy,carcinoma,metastati (1/1),   
Lymph node,axillary, sentinel 2, right,lymphadenectomy,carcinoma,metastatic (1/1),   
Lymph node,axillary, labeled as non-sentinel, right,lymphadenectomy,carcinoma,metastatic (4/5),   
Lymph node,axillary, level I, right,lymphadenectomy,carcinoma,metastatic (8/12),   
Lymph node,axillary, level II, right,lymphadenectomy,carcinoma,metastatic (2/2),   
Lymph node,axillary, sentinel 3, right,lymphadenectomy,no evidence of metastasis (1/1),   
Lymph node,axillary, sentinel 4, right,lymphadenectomy,no evidence of metastasis (1/1),   
 S1223468
Breast,3-6-9 o'clock section margin, status post partial mastectomy, right,partial mastectomy,ductal carcinoma in situ high grade, residual,   
 S1605102
Epidura,T5, 6, 12,laminectomy and excision,carcinoma,metastatic 
臆斷(Tentative Diagnosis) 
1. Septic shock, due to GNB bacteremia, resulted in lactic acidosis and acute kidney injury, under Meropenam(2016/04/22-)
2. Acute respiratory fialure, type IV, status post ETT+MV(2016/04/22-)
3. Acute kidney injury, AKIN stage 3, pre-renal type, under CVVH(2016/04/21-)
4. High grade right breast intraductal carcinoma, pT2N3aM1, stage IV, ER(-), PR(-), Her-2(3+/3+), status right breast conserving therapy and axillary lymph node dissection on 2012/06/08, status post CE90*4 -> TH *4, leuplin (2012/07/16~2012/11/19), status post Herceptin (2012/12/31~2013/9/30), status post adjuvant RT, with brain, lung, liver mets, status post whole brain RT, status post Xeloda + lapatinib(2015/9/8-2016/02/04), disease progression with bone mets and spinal cord compression, status post T5-6, T12 laminectomy for epidural tumor excision and posterior fixation with transpedicular screws on 2016/02/04, s/p oral chemotherapy with UFUR(2cap, BID)  and cyclophosphamide(50mg, QD)(2016/02/28-2016/03/07), s/p oral Vinorelbine(30mg, TIW) in 2016/03/09-3/20, s/p Porta-A implantation on 2016/03/29, s/p Vinorelbine(I) on 2016/04/08(I) and Vinorelbine(II) on 2016/04/15. 
醫療需求與治療計畫(Medical Needs and Care Plan) 
*
1. Septic shock, due to GNB bacteremia in neutropenia, resulted in lactic acidosis and acute kidney injury, under Meropenam(2016/04/22-)
2. Acute respiratory fialure
3. Acute kidney injury,
   S: dyspnea and agitated
   O: tachycardia with restless 
      fatique
      severe meatbolic acidosis with respiratory compensatory
      impending respiratory failure due to fatique
      -> elective intubation
      NG: coffee groud emesis      

      PE: pale conjunctiva and lips
          supple neck
          bilateral coarse breath sounds
          soft abdomen
          no limb edema          

      Lab  WBC: 100/ul
           lactic acid 9
           BUN/Cr: 18/1.1 -> FENa 0.5% 
           ABG: 7.38/19.9/122.6/11.9/-13.5
           pro-BNP >35000             
    
      Bedsides echo:
       1. good heart contraotility,
          no pericardial effusion
       2  right lung consolidation, some pleural effusion
       3. no acsites,  
       4. no hydornephrosis
A: 1. Septic shock, due to GNB bacteremia in neutropenia, resulted in lactic acidosis and acute kidney injury, under Meropenam(2016/04/22-)
2. Acute respiratory fialure, type IV, status post ETT+MV(2016/04/22-)
3. Acute kidney injury, AKIN stage 3, pre-renal type, under CVVH(2016/04/21-)

P:
1. ETT+MV, full support for profund shock
2. start CVVH for metabolic acidosis and AKI,
3. Keep I/O balance for suspect heart failure and shock status
4. keep filgrastin and montior CBC, keep meropenam for neutropenia fever, pending blood culture result
5. well explain, discuss with family if critical condition 
   may introduce palliative and hospice care 

Treatment Goal:
1. MAP>65
2. SpO2 >99
3. RR<30 
出院規劃(Discharge Planning) 
管路留置狀況:有
靜脈管路留置(含Hickman / Port-A)：有 左手 
雙腔導管留置：無 右頸 
鼻胃管留置：無  
氣管管路留置：無    
胃造廔口：無  
尿管留置：有  16Fr. 
膀胱造廔：無 
傷口引流管：無
其他導管：
日常生活功能分數：45
預期出院後居住場所：與家人同住 
預期出院後主要照顧者：配偶 媽媽 
出院規劃收案篩檢：高危病患 帶有管路 功能量表未滿60分 
主治醫師評論(VS Comments) 
I agree with the assessment of the intern. 
醫師姓名 
阮聖元 主治醫師 
